NASDAQ:HOOK
HOOKIPA Pharma Inc. Common Stock
- Stock
Last Close
4.56
24/09 20:00
Market Cap
41.46M
Beta: 0.82
Volume Today
27.39K
Avg: 433.92K
PE Ratio
−0.77
PFCF: −1.39
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | -4.09M - | -11.87M 189.85% | -15.41M 29.79% | -7.84M 49.11% | -209.50K 97.33% | |||
average payables | 2.57M - | 2.30M 10.38% | 4.48M 94.63% | 8.39M 87.32% | 7.13M 15.03% | 8.99M 26.22% | ||
average receivables | 5.72M - | 7.32M 28.04% | 15.19M 107.46% | 20.91M 37.65% | 21.59M 3.24% | 20.64M 4.39% | ||
book value per share | -2.61 - | 2.72 204.09% | 6.60 142.71% | 5.99 9.33% | 2.73 54.41% | 3.93 44.04% | 0.95 75.81% | |
capex per share | -0.08 - | -0.13 65.77% | -0.11 15.02% | -0.09 18.79% | -0.38 321.54% | -0.19 49.80% | -0.04 77.12% | |
capex to depreciation | -3.26 - | -3.36 3.09% | -1.39 58.76% | -0.57 58.76% | -2.71 374.58% | -1.39 48.63% | -1.17 15.93% | |
capex to operating cash flow | 0.11 - | 0.14 31.67% | 0.05 66.58% | 0.06 25.82% | 0.19 216.20% | 0.25 31.65% | 0.07 71.18% | |
capex to revenue | -0.28 - | -0.17 40.60% | -0.12 27.67% | -0.68 463.29% | -0.35 48.37% | -0.21 41.32% | ||
cash per share | 3.76 - | 2.98 20.83% | 6.34 112.89% | 5.49 13.36% | 2.04 62.87% | 4.35 113.41% | 1.24 71.52% | |
days of inventory on hand | ||||||||
days payables outstanding | 1.28K - | |||||||
days sales outstanding | 235.34 - | 297.30 26.33% | 385.00 29.50% | 418.78 8.77% | 563.86 34.64% | 349.44 38.03% | ||
debt to assets | 0.05 - | 0.06 26.93% | 0.07 14.58% | 0.06 24.12% | 0.08 50.65% | 0.04 54.74% | 0.04 6.56% | |
debt to equity | -0.09 - | 0.10 212.88% | 0.09 9.12% | 0.07 25.12% | 0.12 76.18% | 0.06 46.51% | 0.07 15.07% | |
dividend yield | ||||||||
earnings yield | -0.06 - | -0.07 27.62% | -0.16 120.04% | -0.12 25.26% | -0.99 746.45% | -3.08 211.74% | -1.07 65.44% | |
enterprise value | 170.91M - | 184.35M 7.86% | 115.88M 37.14% | 156.60M 35.15% | 20.22M 87.09% | -85.81M 524.50% | -33.97M 60.41% | |
enterprise value over ebitda | -14.59 - | -12.46 14.59% | -2.27 81.80% | -2.94 29.57% | -0.25 91.58% | 1.17 573.93% | 0.42 64.41% | |
ev to operating cash flow | -14.35 - | -12.29 14.33% | -2.78 77.41% | -3.98 43.37% | -0.31 92.31% | 4.29 1,501.39% | 0.59 86.24% | |
ev to sales | 24.16 - | 9.70 59.84% | 8.00 17.59% | 1.10 86.30% | -6.02 649.59% | -1.69 71.98% | ||
free cash flow per share | -0.81 - | -1.05 29.81% | -2.45 133.08% | -1.60 34.69% | -2.39 49.70% | -0.96 59.94% | -0.65 31.95% | |
free cash flow yield | -0.06 - | -0.08 29.81% | -0.20 166.82% | -0.14 27.98% | -1.03 612.52% | -1.18 15.24% | -0.81 31.95% | |
graham net net | -3.07 - | 1.74 156.68% | 5.07 191.10% | 4.57 9.82% | 1.18 74.21% | 2.37 101.02% | 0.64 73.18% | |
graham number | 6.77 - | 7.80 15.25% | 16.85 115.99% | 13.21 21.61% | 11.89 9.96% | 14.86 24.94% | 4.30 71.09% | |
income quality | 0.94 - | 0.92 1.35% | 0.97 4.98% | 0.89 7.97% | 0.87 2.23% | 0.31 64.69% | 0.71 128.90% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -23.36 - | -27.22 16.53% | -58.25 113.97% | -67.79 16.38% | -90.95 34.16% | -106.48 17.08% | -267.91 151.60% | |
interest debt per share | 0.27 - | 0.32 19.01% | 0.64 102.88% | 0.43 32.61% | 0.35 18.95% | 0.28 21.46% | 0.07 73.61% | |
inventory turnover | ||||||||
invested capital | -0.09 - | 0.10 212.88% | 0.09 9.12% | 0.07 25.12% | 0.12 76.18% | 0.06 46.51% | 0.07 15.07% | |
market cap | 228.54M - | 228.54M 0% | 218.43M 4.42% | 289.27M 32.43% | 76.50M 73.55% | 21.13M 72.38% | 76.57M 262.39% | |
net current asset value | -46.43M - | 38.46M 182.83% | 102.17M 165.66% | 139.81M 36.84% | 65.68M 53.02% | 79.26M 20.67% | 75.64M 4.57% | |
net debt to ebitda | 4.92 - | 2.99 39.28% | 2.01 32.79% | 2.49 24.03% | 0.69 72.32% | 1.46 112.12% | 1.36 7.08% | |
net income per share | -0.78 - | -0.99 27.62% | -1.91 92.22% | -1.30 32.22% | -2.30 77.84% | -2.50 8.37% | -0.86 65.44% | |
operating cash flow per share | -0.73 - | -0.92 25.90% | -2.34 154.32% | -1.51 35.45% | -2.01 33.32% | -0.77 61.87% | -0.61 20.62% | |
payables turnover | 0.28 - | |||||||
receivables turnover | 1.55 - | 1.23 20.84% | 0.95 22.78% | 0.87 8.07% | 0.65 25.73% | 1.04 61.36% | ||
research and ddevelopement to revenue | 2.88 - | 3.88 34.70% | 2.80 27.86% | 4.49 60.54% | 4.82 7.27% | 4.29 10.88% | ||
return on tangible assets | -0.17 - | -0.24 37.87% | -0.24 0.15% | -0.18 24.24% | -0.60 233.57% | -0.38 36.34% | -0.51 32.30% | |
revenue per share | 0.47 - | 0.67 43.07% | 0.75 12.29% | 0.56 25.17% | 0.55 2.77% | 0.21 61.02% | ||
roe | 0.30 - | -0.37 222.61% | -0.29 20.80% | -0.22 25.25% | -0.84 290.09% | -0.64 24.76% | -0.91 42.87% | |
roic | 0.36 - | -0.43 219.47% | -0.30 31.24% | -0.24 20.81% | -0.77 226.03% | -0.65 15.83% | -0.85 31.05% | |
sales general and administrative to revenue | 0.90 - | 1.40 56.02% | 0.92 34.03% | 0.94 1.38% | 1.32 40.64% | 0.93 29.69% | ||
shareholders equity per share | -2.61 - | 2.72 204.09% | 6.60 142.71% | 5.99 9.33% | 2.73 54.41% | 3.93 44.04% | 0.95 75.81% | |
stock based compensation to revenue | 0.11 - | 0.47 310.05% | 0.44 5.14% | 0.41 6.26% | 0.35 14.59% | 0.12 67.08% | ||
tangible asset value | -42.66M - | 44.40M 204.09% | 117.90M 165.54% | 156.12M 32.42% | 89.59M 42.61% | 102.52M 14.43% | 89.86M 12.35% | |
tangible book value per share | -2.61 - | 2.72 204.09% | 6.60 142.71% | 5.99 9.33% | 2.73 54.41% | 3.93 44.04% | 0.95 75.81% | |
working capital | 65.92M - | 47.62M 27.77% | 113.26M 137.87% | 150.36M 32.76% | 74.48M 50.47% | 111.56M 49.79% | 105.13M 5.77% |
All numbers in USD (except ratios and percentages)